Replimune Group Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.98

+0.09 (+1.31%)

As of Mar 22, 10:18 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 79%

Hold 3 21%

Sell 0 0%

Price Target

Analyst Price Target +409.3% upside

Low Target $27.68

Average Target $35.55

High Target $47.36

Current Price $6.98

Current
$6.98

Target
$35.55

$27.68 $35.55 avg $47.36

Scenario Analysis

Bear Case

$27.68

296.6%

Low target

Base Case

$35.55

+409.3%

Avg target

Bull Case

$47.36

+578.5%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$14.80

-52.8% from high

52-Week Low

$2.68

+160.4% from low

Target vs 52W High

$35.55

+140.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%